Stay updated on Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial

Sign up to get notified when there's something new on the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T19:01:47.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added Primary peritoneal carcinoma as a study condition and added the Genetic and Rare Diseases Information Center as a resource. Removed the government funding lapse notice and updated the page revision to v3.4.2.
    Difference
    0.6%
    Check dated 2026-02-11T04:14:02.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A site-wide notice regarding government funding and NIH Clinical Center operations was added. The page revision tag was updated to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T05:15:49.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page adds a glossary display option and updates metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0), replacing the previous wording (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T03:49:55.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed, replacing Revision: v3.3.3. This appears to be a backend version update with no changes to the study details or user interactions on the page.
    Difference
    0.1%
    Check dated 2026-01-14T02:28:39.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added Illinois locations under the Locations section. Revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:17:05.000Z thumbnail image

Stay in the know with updates to Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page.